Thiaw, D. , Wade, A. , Sall, M. , Diouf, S. and Dieye, G. (2026) Utilization of Eggshells Waste as an Additive to Improve the Mechanical Properties of Clays. Journal of Minerals and Materials ...

Two dose-limiting toxicities have been recorded in uniQure’s trial evaluating an investigational AAV gene therapy designed to treat the rare condition Fabry disease. In the phase 1/2 study, two ...

A multi-institute team led by Professors Ling Qiu, Baofu Ding and Hui-Ming Cheng has unveiled a two-dimensional titanium-dioxide sunscreen platform that erases the century-old trade-off between safety ...

Patritumab Deruxtecan (HER3-DXd; MK-1022) in Non–Small Cell Lung Cancer After Platinum-Based Chemotherapy and Immunotherapy Many drugs in development continue to follow the historical drug development ...

For patients who have received at least 24 weeks of treatment at the every 2-week dosing schedule and have maintained a response, the dose interval can be switched to an every 4-week schedule. The ...

A more gradual titration significantly reduced the incidence of amyloid-related imaging abnormalities with edema/effusion. The Food and Drug Administration (FDA) has updated the labeling for Kisunla ™ ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. CHICAGO — Novo Nordisk’s ...

Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) administered at off-label reduced dosing maintained weight-loss benefits, with patients retaining the effects even with 2-4 weeks between doses.

Sugammadex doses of 2 and 4 mg/kg, recommended for adults and children aged 2 years or older, were safe and effective for reversing neuromuscular blockade (NMB) in neonates and infants younger than 2 ...